IMAX Corporation

NYSE:IMAX

Entertainment

Communication Services
$46.79 +1.04%

+$0.46 today

Market cap
$2.58B
Beta
0.37
P/E (TTM)
65.9
EPS (TTM)
$0.68
52W Low $24.20High $45.09

Volume 0.95M

Average 1.13M

IMAX Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

IMAX CorporationNYSE: IMAX

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development growth accelerates

Q3 FY2026 research & development of $1.9M rose 26.2% year over year, ahead of the +23.5% change in trailing-twelve-month research & development. Sequentially, it rose 14.8% from the prior quarter. Over 3 fiscal years it compounded at -8.1% a year.

Context

  • Research & development amounted to 1.0% of revenue in FY2025, down 0.4 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +26.2% holds above the trailing-twelve-month pace of +23.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.9M+14.8% QoQ
Last fiscal yearDec 2025
$4.12M-19.3% YoY
LTMSep 2026
$6.81M+23.5% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+26.2%——
1 year-19.3%——
3-year CAGR-8.1%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
4.12M USD
Year-over-year change
-19.3%
4-year CAGR
-12.3%

Research & Development vs competitors

How IMAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +23.5% is the 2nd highest of 5, against a peer median of -1.0%.
  • Research & development amounts to 1.4% of revenue for IMAX, versus a peer median of 1.2%.
IMAX Competitors
Research & Development for IMAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CMPRCimpress plcLTM Mar 2026$347.04M USD+4.6%+4.5%9.5%
IQiQIYI, Inc.LTM Mar 2026CN¥233.03M CNY-83.4%-50.4%6.3%
IRDMIridium Communications Inc.LTM Sep 2026$21.63M USD-6.6%+6.8%2.4%
NNNextNav Inc.LTM Jun 2026$21.49M USD+31.7%+3.6%540.5%
IMAXIMAX CorporationLTM Sep 2026$6.81M USD+23.5%-8.1%1.4%
LIONLionsgate Studios Corp.LTM Jun 2026$0 USD——0.0%
MSGEMadison Square Garden Entertainment Corp.LTM Jun 2026$0 USD——0.0%
AMCAMC Entertainment Holdings, Inc.LTM Jun 2026$0 USD——0.0%
WLYJohn Wiley & Sons, Inc.LTM Jul 2026$0 USD——0.0%
Peer median (excluding IMAX) —-1.0%+4.0%1.2%

Competitors are the stored peer set for IMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue254.88M300.81M374.84M352.21M410.21M
Cost of Revenue120.48M144.45M160.5M162.01M172.64M
Gross Profit134.41M156.36M214.34M190.2M237.57M
Gross Margin52.7%52.0%57.2%54.0%57.9%
Research & Development6.94M5.3M10.11M5.1M4.12M
Selling, General & Admin117.79M138.04M144.41M132.7M137.85M
Operating Expenses123.42M161.19M163.94M146.34M141.97M
Depreciation & Amortization56.08M56.66M60.02M65.5M62.45M
EBITDA74.16M52.77M112.96M111.29M133.1M
EBITDA Margin29.1%17.5%30.1%31.6%32.4%
Operating Income10.98M(4.83M)50.4M43.86M95.6M
Operating Margin4.3%-1.6%13.4%12.5%23.3%
Interest Income2.22M1.43M2.49M2.18M2.8M
Interest Expense7.09M5.88M6.82M8.08M7.36M
Other Income / Expenses3K(4.94M)(4.28M)(6.16M)(32.31M)
Income Before Tax10.99M(9.77M)46.12M37.7M63.29M
Pre-Tax Margin4.3%-3.2%12.3%10.7%15.4%
Income Tax Expense20.56M10.11M13.05M5M17.77M
Net Income(22.33M)(22.8M)25.34M26.06M34.88M
Net Margin-8.8%-7.6%6.8%7.4%8.5%
EPS (Basic)(0.38)(0.40)0.470.490.65
EPS (Diluted)(0.38)(0.40)0.460.480.63
Weighted Avg Shares59.13M56.67M54.31M52.65M53.64M
Weighted Avg Shares (Diluted)59.13M56.67M55.15M53.86M55.54M

IMAX Corporation

NYSE:IMAX

Intrinsic Alpha fair value

Locked

Current Price

$46.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.